119 related articles for article (PubMed ID: 38631661)
1. A mutual regulatory loop between transcription factor Yin Yang 1 and hepatitis B virus replication influences chronic hepatitis B.
Zhou J; Hua Y; Liu Y; Wu T; Xu H; Wang Z; Wang X; Niu J
Antiviral Res; 2024 Jun; 226():105889. PubMed ID: 38631661
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B surface antigen: relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B.
Manesis EK; Papatheodoridis GV; Tiniakos DG; Hadziyannis ES; Agelopoulou OP; Syminelaki T; Papaioannou C; Nastos T; Karayiannis P
J Hepatol; 2011 Jul; 55(1):61-8. PubMed ID: 21145875
[TBL] [Abstract][Full Text] [Related]
3. Changes of HBsAg and HBV DNA levels in Chinese chronic hepatitis B patients after 5 years of entecavir treatment.
Seto WK; Lam YF; Fung J; Wong DK; Huang FY; Hung IF; Lai CL; Yuen MF
J Gastroenterol Hepatol; 2014 May; 29(5):1028-34. PubMed ID: 24325451
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment serum HBsAg-to-HBV DNA ratio predicts a virologic response to entecavir in chronic hepatitis B.
Song JC; Min BY; Kim JW; Kim JY; Kim YM; Shin CM; Lee SH; Hwang JH; Jeong SH; Kim N; Lee DH
Korean J Hepatol; 2011 Dec; 17(4):268-73. PubMed ID: 22310791
[TBL] [Abstract][Full Text] [Related]
5. IP-10 Expression in Patients with Chronic HBV Infection and Its Ability to Predict the Decrease in HBsAg Levels after Treatment with Entecavir.
Zhao K; Yang T; Sun M; Zhang W; An Y; Chen G; Jin L; Shang Q; Song W
Mol Cells; 2017 Jun; 40(6):418-425. PubMed ID: 28614914
[TBL] [Abstract][Full Text] [Related]
6. Analysis of intrahepatic total HBV DNA, cccDNA and serum HBsAg level in Chronic Hepatitis B patients with undetectable serum HBV DNA during oral antiviral therapy.
Li J; Sun X; Fang J; Wang C; Han G; Ren W
Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):635-643. PubMed ID: 28438570
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of intrahepatic hepatitis B virus covalently closed circular DNA and total DNA in patients with acute hepatitis B and patients with chronic hepatitis B receiving anti‑viral treatment.
Ruan P; Zhou B; Dai X; Sun Z; Guo X; Huang J; Gong Z
Mol Med Rep; 2014 Apr; 9(4):1135-41. PubMed ID: 24566465
[TBL] [Abstract][Full Text] [Related]
8. Correlation between intrahepatic hepatitis B virus cccDNA levels and other activity markers in patients with HBeAg-negative chronic hepatitis B infection.
Guner R; Karahocagil M; Buyukberber M; Kandemir O; Ural O; Usluer G; Inan D; Koksal I; Baykam N; Hizel K; Yamazhan T; Esen S; Tasyaran MA
Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1185-91. PubMed ID: 21934508
[TBL] [Abstract][Full Text] [Related]
9. Serum Hepatitis B Virus DNA, RNA, and HBsAg: Which Correlated Better with Intrahepatic Covalently Closed Circular DNA before and after Nucleos(t)ide Analogue Treatment?
Gao Y; Li Y; Meng Q; Zhang Z; Zhao P; Shang Q; Li Y; Su M; Li T; Liu X; Zhuang H
J Clin Microbiol; 2017 Oct; 55(10):2972-2982. PubMed ID: 28747369
[TBL] [Abstract][Full Text] [Related]
10. Application strategies of serum HBV DNA detection in HBV infection patients: A retrospective study of 5611 specimens.
Liu C; Wu W; Shang S; Huang E; Xun Z; Lin J; Chen T; Yang B; Chen J; Ou Q
J Med Virol; 2019 Feb; 91(2):249-257. PubMed ID: 30011350
[TBL] [Abstract][Full Text] [Related]
11. Analysis of hepatitis B virus intrahepatic covalently closed circular DNA and serum viral markers in treatment-naive patients with acute and chronic HBV infection.
Li W; Zhao J; Zou Z; Liu Y; Li B; Sun Y; Li X; Liu S; Cai S; Yao W; Xin S; Lu F; Xu D
PLoS One; 2014; 9(2):e89046. PubMed ID: 24551214
[TBL] [Abstract][Full Text] [Related]
12. Quantitative hepatitis B surface antigen levels in patients with chronic hepatitis B after 2 years of entecavir treatment.
Fung J; Lai CL; Young J; Wong DK; Yuen J; Seto WK; Yuen MF
Am J Gastroenterol; 2011 Oct; 106(10):1766-73. PubMed ID: 21826112
[TBL] [Abstract][Full Text] [Related]
13. Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers.
Thompson AJ; Nguyen T; Iser D; Ayres A; Jackson K; Littlejohn M; Slavin J; Bowden S; Gane EJ; Abbott W; Lau GK; Lewin SR; Visvanathan K; Desmond PV; Locarnini SA
Hepatology; 2010 Jun; 51(6):1933-44. PubMed ID: 20512987
[TBL] [Abstract][Full Text] [Related]
14. Effects of amino acid substitutions in hepatitis B virus surface protein on virion secretion, antigenicity, HBsAg and viral DNA.
Xiang KH; Michailidis E; Ding H; Peng YQ; Su MZ; Li Y; Liu XE; Dao Thi VL; Wu XF; Schneider WM; Rice CM; Zhuang H; Li T
J Hepatol; 2017 Feb; 66(2):288-296. PubMed ID: 27650283
[TBL] [Abstract][Full Text] [Related]
15. Anti-HBV drugs suppress the growth of HBV-related hepatoma cells via down-regulation of hepatitis B virus X protein.
Zhang S; Gao S; Zhao M; Liu Y; Bu Y; Jiang Q; Zhao Q; Ye L; Zhang X
Cancer Lett; 2017 Apr; 392():94-104. PubMed ID: 28192212
[TBL] [Abstract][Full Text] [Related]
16. Baseline and kinetics of serum hepatitis B virus RNA predict response to pegylated interferon-based therapy in patients with hepatitis B e antigen-negative chronic hepatitis B.
Limothai U; Chuaypen N; Poovorawan K; Chotiyaputta W; Tanwandee T; Poovorawan Y; Tangkijvanich P
J Viral Hepat; 2019 Dec; 26(12):1481-1488. PubMed ID: 31446638
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms downstream of reverse transcription reduce serum levels of HBV DNA but not of HBsAg in chronic hepatitis B virus infection.
Larsson SB; Malmström S; Hannoun C; Norkrans G; Lindh M
Virol J; 2015 Dec; 12():213. PubMed ID: 26645241
[TBL] [Abstract][Full Text] [Related]
18. Serum HBV DNA plus RNA shows superiority in reflecting the activity of intrahepatic cccDNA in treatment-naïve HBV-infected individuals.
Huang H; Wang J; Li W; Chen R; Chen X; Zhang F; Xu D; Lu F
J Clin Virol; 2018; 99-100():71-78. PubMed ID: 29353073
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus DNA and hepatitis B surface antigen levels in chronic hepatitis B.
Fung J; Lai CL; Yuen MF
Expert Rev Anti Infect Ther; 2010 Jun; 8(6):717-26. PubMed ID: 20521898
[TBL] [Abstract][Full Text] [Related]
20. HoxA10 Facilitates SHP-1-Catalyzed Dephosphorylation of p38 MAPK/STAT3 To Repress Hepatitis B Virus Replication by a Feedback Regulatory Mechanism.
Yang Q; Zhang Q; Zhang X; You L; Wang W; Liu W; Han Y; Ma C; Xu W; Chen J; Yang H; Wan P; Zhou Y; Liu Y; Wu K; Yang Z; Wu J
J Virol; 2019 Apr; 93(7):. PubMed ID: 30674631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]